Cyclo Therapeutics- Warrants (14/11/2025) Profit Margin

The latest profit margin for CYTHW is -2848.16% as of September 2024. That compares with -2019.93% in the prior-year period — down 41.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Cyclo Therapeutics- Warrants (14/11/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CYTHW's profit margin moved from -2019.93% to -2848.16% — a 41.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cyclo Therapeutics- Warrants (14/11/2025)'s valuation or profitability profile.

Against Healthcare companies, CYTHW currently prints -2848.16% for profit margin, while the sector average sits near 14.34%. That is roughly 19955.0% below the sector mean. Large gaps often invite a closer look at Cyclo Therapeutics- Warrants (14/11/2025)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Cyclo Therapeutics- Warrants (14/11/2025) converts resources into returns. At -2848.16%, CYTHW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2019.93% in the prior-year period — down 41.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CYTHW's profit margin (-2848.16%), review year-over-year change from -2019.93%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.